|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Phaedrus
|
288 |
85K |
16 |
11/04/26 |
| 11/04/26 |
ASX - By Stock
|
288
|
85K
|
16
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears Ryoncil IND for Registration Trial in DMD
|
|
Phaedrus
|
40 |
16K |
13 |
10/04/26 |
| 10/04/26 |
ASX - By Stock
|
40
|
16K
|
13
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Phaedrus
|
288 |
85K |
77 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
288
|
85K
|
77
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Phaedrus
|
288 |
85K |
10 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
288
|
85K
|
10
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Phaedrus
|
288 |
85K |
62 |
08/04/26 |
| 08/04/26 |
ASX - By Stock
|
288
|
85K
|
62
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
21 |
26/03/26 |
| 26/03/26 |
ASX - By Stock
|
21K
|
9.0M
|
21
|
|
|
ASX - By Stock
|
MSB |
Re:
R&D day
|
|
Phaedrus
|
155 |
63K |
29 |
17/03/26 |
| 17/03/26 |
ASX - By Stock
|
155
|
63K
|
29
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
21K |
7.7M |
40 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
21K
|
7.7M
|
40
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
16 |
07/02/26 |
| 07/02/26 |
ASX - By Stock
|
21K
|
9.0M
|
16
|
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
Phaedrus
|
545 |
289K |
82 |
02/02/26 |
| 02/02/26 |
ASX - By Stock
|
545
|
289K
|
82
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
21K |
7.7M |
1 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
21K
|
7.7M
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
21K |
7.7M |
61 |
22/01/26 |
| 22/01/26 |
ASX - By Stock
|
21K
|
7.7M
|
61
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
21K |
7.7M |
59 |
20/01/26 |
| 20/01/26 |
ASX - By Stock
|
21K
|
7.7M
|
59
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
21K |
7.7M |
2 |
20/01/26 |
| 20/01/26 |
ASX - By Stock
|
21K
|
7.7M
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
33 |
15/01/26 |
| 15/01/26 |
ASX - By Stock
|
21K
|
9.0M
|
33
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
24 |
07/01/26 |
| 07/01/26 |
ASX - By Stock
|
21K
|
9.0M
|
24
|
|
|
ASX - By Stock
|
MSB |
Re:
$3 Party
|
|
Phaedrus
|
283 |
107K |
41 |
30/12/25 |
| 30/12/25 |
ASX - By Stock
|
283
|
107K
|
41
|
|
|
ASX - By Stock
|
MSB |
Re:
$3 Party
|
|
Phaedrus
|
283 |
107K |
47 |
26/12/25 |
| 26/12/25 |
ASX - By Stock
|
283
|
107K
|
47
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
Phaedrus
|
912 |
289K |
47 |
19/12/25 |
| 19/12/25 |
ASX - By Stock
|
912
|
289K
|
47
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
42 |
15/12/25 |
| 15/12/25 |
ASX - By Stock
|
21K
|
9.0M
|
42
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
28 |
15/12/25 |
| 15/12/25 |
ASX - By Stock
|
21K
|
9.0M
|
28
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Participation at Piper Sandler Conference
|
|
Phaedrus
|
78 |
32K |
31 |
06/12/25 |
| 06/12/25 |
ASX - By Stock
|
78
|
32K
|
31
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
Phaedrus
|
3.2K |
1.3M |
32 |
01/12/25 |
| 01/12/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
32
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
Phaedrus
|
3.2K |
1.3M |
99 |
30/11/25 |
| 30/11/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
99
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
Phaedrus
|
3.2K |
1.3M |
34 |
29/11/25 |
| 29/11/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
34
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
Phaedrus
|
3.2K |
1.3M |
55 |
28/11/25 |
| 28/11/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
55
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
Phaedrus
|
860 |
333K |
6 |
28/11/25 |
| 28/11/25 |
ASX - By Stock
|
860
|
333K
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
BP Healthcare Conference 20-11-25
|
|
Phaedrus
|
180 |
51K |
3 |
24/11/25 |
| 24/11/25 |
ASX - By Stock
|
180
|
51K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
BP Healthcare Conference 20-11-25
|
|
Phaedrus
|
180 |
51K |
1 |
24/11/25 |
| 24/11/25 |
ASX - By Stock
|
180
|
51K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
BP Healthcare Conference 20-11-25
|
|
Phaedrus
|
180 |
51K |
6 |
23/11/25 |
| 23/11/25 |
ASX - By Stock
|
180
|
51K
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
101 |
23/11/25 |
| 23/11/25 |
ASX - By Stock
|
21K
|
9.0M
|
101
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
64 |
22/11/25 |
| 22/11/25 |
ASX - By Stock
|
21K
|
9.0M
|
64
|
|
|
ASX - By Stock
|
MSB |
Re:
BP Healthcare Conference 20-11-25
|
|
Phaedrus
|
180 |
51K |
17 |
22/11/25 |
| 22/11/25 |
ASX - By Stock
|
180
|
51K
|
17
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appointment of Chief Financial Officer
|
|
Phaedrus
|
113 |
37K |
12 |
18/11/25 |
| 18/11/25 |
ASX - By Stock
|
113
|
37K
|
12
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
8 |
18/11/25 |
| 18/11/25 |
ASX - By Stock
|
21K
|
9.0M
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA meeting on Rexlemestrocel-L, CLBP and Opioid Cessation
|
|
Phaedrus
|
389 |
127K |
4 |
13/11/25 |
| 13/11/25 |
ASX - By Stock
|
389
|
127K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA meeting on Rexlemestrocel-L, CLBP and Opioid Cessation
|
|
Phaedrus
|
389 |
127K |
4 |
13/11/25 |
| 13/11/25 |
ASX - By Stock
|
389
|
127K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
6 |
29/10/25 |
| 29/10/25 |
ASX - By Stock
|
21K
|
9.0M
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
47 |
28/10/25 |
| 28/10/25 |
ASX - By Stock
|
21K
|
9.0M
|
47
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Receives CMS (Medicaid) J-Code for Reimbursement
|
|
Phaedrus
|
100 |
36K |
29 |
06/10/25 |
| 06/10/25 |
ASX - By Stock
|
100
|
36K
|
29
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Receives CMS (Medicaid) J-Code for Reimbursement
|
|
Phaedrus
|
100 |
36K |
28 |
06/10/25 |
| 06/10/25 |
ASX - By Stock
|
100
|
36K
|
28
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
Phaedrus
|
140 |
40K |
46 |
17/09/25 |
| 17/09/25 |
ASX - By Stock
|
140
|
40K
|
46
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
6 |
15/09/25 |
| 15/09/25 |
ASX - By Stock
|
21K
|
9.0M
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Phaedrus
|
21K |
9.0M |
30 |
15/09/25 |
| 15/09/25 |
ASX - By Stock
|
21K
|
9.0M
|
30
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
21K |
7.7M |
8 |
11/09/25 |
| 11/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Phaedrus
|
21K |
7.7M |
15 |
06/09/25 |
| 06/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
15
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
Phaedrus
|
3.2K |
1.3M |
53 |
04/09/25 |
| 04/09/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
53
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
Phaedrus
|
3.2K |
1.3M |
58 |
02/09/25 |
| 02/09/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
58
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
Phaedrus
|
321 |
99K |
3 |
01/09/25 |
| 01/09/25 |
ASX - By Stock
|
321
|
99K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
Phaedrus
|
321 |
99K |
5 |
01/09/25 |
| 01/09/25 |
ASX - By Stock
|
321
|
99K
|
5
|
|